McCracken Joseph S

SEC source: 0001193125-26-055175 · ownership.xml · derivative · entry 2

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,807 shares

Expires 2026-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2017.

SEC source: 0001193125-26-055175 · ownership.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,644

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001193125-25-316296 · ownership.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,837

F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer.

SEC source: 0000950170-25-080021 · ownership.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,837

F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.08 to $2.085. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

SEC source: 0001126234-24-000111 · wk-form4_1734143432.xml · derivative · entry 6

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,910 shares

Expires 2031-05-19

F3 · price: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

F3 · derivative.exercise_date: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

SEC source: 0001126234-24-000111 · wk-form4_1734143432.xml · derivative · entry 5

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,431 shares

Expires 2032-05-04

F3 · price: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

F3 · derivative.exercise_date: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

SEC source: 0001126234-24-000111 · wk-form4_1734143432.xml · derivative · entry 4

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,684 shares

Expires 2030-04-02

F3 · price: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

F3 · derivative.exercise_date: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.

SEC source: 0001126234-24-000111 · wk-form4_1734143432.xml · derivative · entry 3

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,328 shares

Expires 2034-06-04

F2 · price: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.

F2 · derivative.exercise_date: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.

SEC source: 0001126234-24-000111 · wk-form4_1734143432.xml · derivative · entry 2

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,345 shares

Expires 2033-05-09

F2 · price: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.

F2 · derivative.exercise_date: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.

SEC source: 0001126234-24-000111 · wk-form4_1734143432.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share.

SEC source: 0000950170-24-136770 · ownership.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,837

F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer.

SEC source: 0000950170-24-129007 · ownership.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,837

F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.9481 to $2.9678. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

SEC source: 0001126234-24-000077 · wk-form4_1717790861.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,328

Underlying: Common Stock · 3,328 shares

Expires 2034-06-04

F1 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.

SEC source: 0001209191-23-058841 · doc4.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,837

F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 14, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001126234-23-000071 · wf-form4_168392786065137.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,345

Underlying: Common Stock · 3,345 shares

Expires 2033-05-09

F1 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.

SEC source: 0001209191-22-061424 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2032-12-13

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 13, 2023.

SEC source: 0001126234-22-000114 · wf-form4_166880708979109.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,721

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.005 to $5.0536, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4.

F2 · balance_after: Includes 237 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a single installment on April 3, 2023, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

SEC source: 0001126234-22-000092 · wf-form4_166154755894555.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,721

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.52 to $8.85, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4.

F2 · balance_after: Includes 237 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a single installment on April 3, 2023, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

SEC source: 0001126234-22-000055 · wf-form4_165213058031730.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,431

Underlying: Common Stock · 3,431 shares

Expires 2032-05-04

F1 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.

SEC source: 0001209191-21-069585 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2031-12-14

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 14, 2022.

SEC source: 0001250853-21-000085 · primary_doc.xml · derivative · entry 5

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,500 shares

Expires 2031-01-19

F5 · price: This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $233,285.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.

F5 · derivative.exercise_date: This option provided for vesting in four equal quarterly installments from the option grant date. Pursuant to the Merger Agreement, the unvested portion of this option was subject to acceleration of vesting. This option was cancelled pursuant to the Merger Agreement in exchange for a cash payment of $233,285.00, representing the difference between the per share exercise price of the option and the merger consideration of $9.25 per share.

SEC source: 0001250853-21-000085 · primary_doc.xml · derivative · entry 4

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,500 shares

Expires 2030-01-16

F4 · price: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.

F4 · derivative.exercise_date: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.

SEC source: 0001250853-21-000085 · primary_doc.xml · derivative · entry 3

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 48,500 shares

Expires 2029-01-31

F3 · price: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.

F3 · derivative.exercise_date: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.

SEC source: 0001250853-21-000085 · primary_doc.xml · derivative · entry 2

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2028-06-21

F2 · price: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.

F2 · derivative.exercise_date: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the Merger Agreement in exchange for no consideration.

SEC source: 0001250853-21-000085 · primary_doc.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,890 shares

Expires 2028-04-19

F1 · price: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement") in exchange for no consideration.

F1 · derivative.exercise_date: This option provided for vesting in four equal quarterly installments from the option grant date. This option was cancelled pursuant to the agreement and plan of merger, dated as of June 15, 2021, by and among the Elanco Animal Health Incorporated, Knight Merger Sub, Inc., and Kindred Biosciences, Inc. (the "Merger Agreement") in exchange for no consideration.

SEC source: 0001126234-21-000112 · wf-form4_162888669898993.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,551

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.475 to $7.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4.

F2 · balance_after: Includes 473 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2010 Non-Employee Directors' Stock Award Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 3, 2022, in each case subject to the Reporting Person's continuous service as of such date.

SEC source: 0001126234-21-000081 · wf-form4_162189577929307.xml · derivative · entry 2

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,910

Underlying: Common Stock · 2,910 shares

Expires 2031-05-19

F3 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Plan. One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant.

SEC source: 0001126234-21-000081 · wf-form4_162189577929307.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,076

F1 · shares: Represents shares issued as restricted stock units ("RSUs") under the Issuer's 2010 Non-Employee Director Stock Award Plan (the "Plan") that were received as an award, for no consideration. The RSUs vest in a single installment on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

F2 · balance_after: Includes 473 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of two successive annual installments with the next installment occurring on April 3, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

SEC source: 0001209191-21-020415 · doc4.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,337

SEC source: 0001250853-21-000019 · primary_doc.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,500

Underlying: Common Stock · 48,500 shares

Expires 2031-01-19

F1 · derivative.exercise_date: The option will vest in four equal quarterly installments from the option grant date.

SEC source: 0001209191-20-063978 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2030-12-16

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021.

SEC source: 0001126234-20-000062 · wf-form4_158629668273144.xml · derivative · entry 2

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,684

Underlying: Common Stock · 5,684 shares

Expires 2030-04-02

F2 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Plan. One-third of the shares vest on the one-year anniversary of the grant date and the remaining two-thirds of the shares vest in a series of 24 successive equal monthly installments thereafter, subject to the Reporting Persons's continuous service as of such dates. The option expires ten years after the date of grant, unless it expires sooner pursuant to the terms of the Plan.

SEC source: 0001126234-20-000062 · wf-form4_158629668273144.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 709

F1 · shares: Represents shares issued as restricted stock units ("RSUs") under the Issuer's 2010 Non-Employee Director Stock Award Plan (the "Plan") that were received as an award, for no consideration. The RSUs vest in a series of three successive annual installments beginning on April 3, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.

SEC source: 0001250853-20-000032 · primary_doc.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,500

Underlying: Common Stock · 48,500 shares

Expires 2030-01-16

F1 · derivative.exercise_date: The option will vest in four equal quarterly installments from the option grant date.

SEC source: 0000899243-19-030067 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2029-12-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 8

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,807

Underlying: Common Stock · 9,034 shares

Expires 2026-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal quarterly installments beginning on March 15, 2017.

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 7

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,860 shares

Expires 2025-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 15, 2016.

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 6

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,930 shares

Expires 2024-07-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on October 24, 2014.

SEC source: 0000899243-19-019303 · doc4.xml · derivative · entry 5

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,682 shares

Expires 2023-11-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on January 15, 2014.

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 4

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,372

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 3

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,338

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 2

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,478

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-19-019303 · doc4.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,548

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001250853-19-000040 · primary_doc.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,500

Underlying: Common Stock · 48,500 shares

Expires 2029-01-31

F1 · derivative.exercise_date: The option will vest in four equal quarterly installments from the option grant date.

SEC source: 0000899243-18-031088 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common Stock · 12,000 shares

Expires 2028-12-13

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 13, 2018, subject to the reporting person's continued service with the Issuer.

SEC source: 0001250853-18-000093 · primary_doc.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-06-21

F1 · derivative.exercise_date: The option will vest in four equal quarterly installments following the grant date.

SEC source: 0001250853-18-000066 · primary_doc.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,890

Underlying: Common Stock · 41,890 shares

Expires 2028-04-19

F1 · derivative.exercise_date: The option will vest in four quarterly installments following the grant date.

SEC source: 0000899243-17-029244 · doc4.xml · derivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,750

Underlying: Common Stock · 3,750 shares

Expires 2027-12-17

F1 · derivative.exercise_date: The option vests and becomes exercisable in six equal monthly installments on each monthly anniversary of December 17, 2017, subject to the reporting person's continued service with the Issuer.

SEC source: 0001572426-17-000034 · edgar.xml · nonDerivative · entry 1

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer.

SEC source: 0001171000-17-000047 · edgar.xml · derivative · entry 4

McCracken Joseph S · CIK 0001632454 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 3,600 shares

Expires 2021-07-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.